Guardant Health (NASDAQ:GH – Get Free Report) and Tenet Healthcare (NYSE:THC – Get Free Report) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation and dividends.
Valuation & Earnings
This table compares Guardant Health and Tenet Healthcare”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Guardant Health | $982.02 million | 19.74 | -$416.28 million | ($3.68) | -38.93 |
| Tenet Healthcare | $21.31 billion | 1.05 | $1.41 billion | $34.48 | 8.19 |
Tenet Healthcare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than Tenet Healthcare, indicating that it is currently the more affordable of the two stocks.
Volatility and Risk
Guardant Health has a beta of 1.67, indicating that its stock price is 67% more volatile than the S&P 500. Comparatively, Tenet Healthcare has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500.
Analyst Recommendations
This is a summary of recent ratings and price targets for Guardant Health and Tenet Healthcare, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Guardant Health | 1 | 0 | 24 | 1 | 2.96 |
| Tenet Healthcare | 0 | 3 | 19 | 0 | 2.86 |
Guardant Health currently has a consensus price target of $190.88, indicating a potential upside of 33.22%. Tenet Healthcare has a consensus price target of $296.65, indicating a potential upside of 5.07%. Given Guardant Health’s stronger consensus rating and higher possible upside, analysts plainly believe Guardant Health is more favorable than Tenet Healthcare.
Insider and Institutional Ownership
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 95.4% of Tenet Healthcare shares are held by institutional investors. 5.6% of Guardant Health shares are held by company insiders. Comparatively, 1.0% of Tenet Healthcare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Profitability
This table compares Guardant Health and Tenet Healthcare’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Guardant Health | -37.93% | N/A | -25.03% |
| Tenet Healthcare | 13.09% | 28.22% | 6.12% |
Summary
Tenet Healthcare beats Guardant Health on 8 of the 15 factors compared between the two stocks.
About Guardant Health
Guardant Health is a precision oncology company that develops blood- and tissue-based tests to help guide cancer care. Founded in 2012 by Helmy Eltoukhy and AmirAli Talasaz, the company focuses on using genomic information to support cancer detection, treatment selection and disease monitoring. Its products include Guardant360 tests, which analyze tumor-related genetic changes to help inform treatment decisions, and Guardant Reveal, which is designed to detect residual or recurring cancer after treatment.
About Tenet Healthcare
Tenet Healthcare Corporation is a U.S.-based healthcare services company that operates acute care hospitals and provides related inpatient and outpatient services. Its hospitals offer services across areas such as emergency care, surgery, imaging and specialty treatment. Through its subsidiary United Surgical Partners International (USPI), Tenet also operates ambulatory surgery centers and surgical hospitals, providing outpatient surgical and procedural care. The company’s Conifer Health Solutions business provides revenue cycle management and other administrative services to healthcare providers.
Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.
